Recommendations of the Alzheimer's disease-related dementias conference

The National Alzheimer's Project Act, signed into law in 2011, mandates a National Plan to Address Alzheimer's Disease that is updated annually. In the Plan, the term Alzheimer disease includes not only Alzheimer disease (AD) proper, but also several specified related dementias, namely, fr...

Full description

Saved in:
Bibliographic Details
Published inNeurology Vol. 83; no. 9; p. 851
Main Authors Montine, Thomas J, Koroshetz, Walter J, Babcock, Debra, Dickson, Dennis W, Galpern, Wendy R, Glymour, M Maria, Greenberg, Steven M, Hutton, Michael L, Knopman, David S, Kuzmichev, Andrey N, Manly, Jennifer J, Marder, Karen S, Miller, Bruce L, Phelps, Creighton H, Seeley, William W, Sieber, Beth-Anne, Silverberg, Nina B, Sutherland, Margaret, Torborg, Christine L, Waddy, Salina P, Zlokovic, Berislav V, Corriveau, Roderick A
Format Journal Article
LanguageEnglish
Published United States 26.08.2014
Subjects
Alzheimer Disease
Dementia
Humans
United States
United States
Online AccessGet more information

Cover

Abstract The National Alzheimer's Project Act, signed into law in 2011, mandates a National Plan to Address Alzheimer's Disease that is updated annually. In the Plan, the term Alzheimer disease includes not only Alzheimer disease (AD) proper, but also several specified related dementias, namely, frontotemporal, Lewy body, vascular, and mixed dementia. In response to a specific action item in the 2012 National Plan, the National Institute of Neurological Disorders and Stroke, in collaboration with the National Institute on Aging, convened panels of experts and conducted a 2-day public conference to develop research priorities and timelines for addressing Alzheimer disease-related dementias (ADRD) in 5 topic areas: multiple etiology dementias, health disparities, Lewy body dementias including dementia with Lewy bodies and Parkinson disease dementia, frontotemporal dementia and related tauopathies, and vascular contributions to ADRD. By design, the product was up to 8 prioritized research recommendations in each topic area including estimated timelines from when work on a recommendation is started to completion or to full implementation of an ongoing activity, and recognition of shared research themes across recommendations. These included increased education and training of both researchers and health care professionals, addressing health disparities, fundamental neurobiology research, advanced diagnostics, collaborative biosample repositories, and a focus on developing effective interventions to prevent or treat ADRD by the year 2025 as targeted by the National Plan.
AbstractList The National Alzheimer's Project Act, signed into law in 2011, mandates a National Plan to Address Alzheimer's Disease that is updated annually. In the Plan, the term Alzheimer disease includes not only Alzheimer disease (AD) proper, but also several specified related dementias, namely, frontotemporal, Lewy body, vascular, and mixed dementia. In response to a specific action item in the 2012 National Plan, the National Institute of Neurological Disorders and Stroke, in collaboration with the National Institute on Aging, convened panels of experts and conducted a 2-day public conference to develop research priorities and timelines for addressing Alzheimer disease-related dementias (ADRD) in 5 topic areas: multiple etiology dementias, health disparities, Lewy body dementias including dementia with Lewy bodies and Parkinson disease dementia, frontotemporal dementia and related tauopathies, and vascular contributions to ADRD. By design, the product was up to 8 prioritized research recommendations in each topic area including estimated timelines from when work on a recommendation is started to completion or to full implementation of an ongoing activity, and recognition of shared research themes across recommendations. These included increased education and training of both researchers and health care professionals, addressing health disparities, fundamental neurobiology research, advanced diagnostics, collaborative biosample repositories, and a focus on developing effective interventions to prevent or treat ADRD by the year 2025 as targeted by the National Plan.
Author Torborg, Christine L
Montine, Thomas J
Galpern, Wendy R
Greenberg, Steven M
Hutton, Michael L
Waddy, Salina P
Koroshetz, Walter J
Babcock, Debra
Zlokovic, Berislav V
Glymour, M Maria
Sieber, Beth-Anne
Silverberg, Nina B
Manly, Jennifer J
Kuzmichev, Andrey N
Phelps, Creighton H
Dickson, Dennis W
Sutherland, Margaret
Corriveau, Roderick A
Knopman, David S
Seeley, William W
Marder, Karen S
Miller, Bruce L
Author_xml – sequence: 1
  givenname: Thomas J
  surname: Montine
  fullname: Montine, Thomas J
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 2
  givenname: Walter J
  surname: Koroshetz
  fullname: Koroshetz, Walter J
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 3
  givenname: Debra
  surname: Babcock
  fullname: Babcock, Debra
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 4
  givenname: Dennis W
  surname: Dickson
  fullname: Dickson, Dennis W
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 5
  givenname: Wendy R
  surname: Galpern
  fullname: Galpern, Wendy R
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 6
  givenname: M Maria
  surname: Glymour
  fullname: Glymour, M Maria
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 7
  givenname: Steven M
  surname: Greenberg
  fullname: Greenberg, Steven M
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 8
  givenname: Michael L
  surname: Hutton
  fullname: Hutton, Michael L
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 9
  givenname: David S
  surname: Knopman
  fullname: Knopman, David S
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 10
  givenname: Andrey N
  surname: Kuzmichev
  fullname: Kuzmichev, Andrey N
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 11
  givenname: Jennifer J
  surname: Manly
  fullname: Manly, Jennifer J
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 12
  givenname: Karen S
  surname: Marder
  fullname: Marder, Karen S
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 13
  givenname: Bruce L
  surname: Miller
  fullname: Miller, Bruce L
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 14
  givenname: Creighton H
  surname: Phelps
  fullname: Phelps, Creighton H
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 15
  givenname: William W
  surname: Seeley
  fullname: Seeley, William W
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 16
  givenname: Beth-Anne
  surname: Sieber
  fullname: Sieber, Beth-Anne
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 17
  givenname: Nina B
  surname: Silverberg
  fullname: Silverberg, Nina B
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 18
  givenname: Margaret
  surname: Sutherland
  fullname: Sutherland, Margaret
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 19
  givenname: Christine L
  surname: Torborg
  fullname: Torborg, Christine L
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 20
  givenname: Salina P
  surname: Waddy
  fullname: Waddy, Salina P
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 21
  givenname: Berislav V
  surname: Zlokovic
  fullname: Zlokovic, Berislav V
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA
– sequence: 22
  givenname: Roderick A
  surname: Corriveau
  fullname: Corriveau, Roderick A
  email: roderick.corriveau@nih.gov
  organization: From the Department of Pathology (T.J.M.), University of Washington, Seattle; National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD; Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL; Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco; Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK; Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York; Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY; University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.); National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD; and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA. roderick.corriveau@nih.gov
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25080517$$D View this record in MEDLINE/PubMed
BookMark eNpNj81KAzEYRYMo9kffQCQ7V1Pzn3RZilZhUBBFd-VL8oWOzGTKZFzo01tQwbu5cLgcuDNynPuMhFxwtuCCi-vXh3rB_sdKeUSmXAtTGSneJmRWyjtjB2CXp2QiNHNMczslmycMfddhjjA2fS60T3TcIV21XztsOhyuCo1NQShYDdjCiJFGPOzHBgoNfU44YA54Rk4StAXPf3tOXm5vntd3Vf24uV-v6ipoZ2SlYjLKJpCWW6cMX_qgTQKhFXilGGfWu6iSEYaD104y71lYWrDScYVGizm5_PHuP3yHcbsfmg6Gz-3fI_ENk_RNvw
CitedBy_id crossref_primary_10_1016_j_ajpath_2015_12_001
crossref_primary_10_1089_neu_2021_0216
crossref_primary_10_1007_s11357_022_00571_x
crossref_primary_10_2196_54032
crossref_primary_10_1371_journal_pone_0289435
crossref_primary_10_1186_s13195_019_0521_0
crossref_primary_10_1016_j_jcmg_2020_10_018
crossref_primary_10_1093_jnen_nlw033
crossref_primary_10_1161_STROKEAHA_120_031611
crossref_primary_10_12677_ACM_2018_82031
crossref_primary_10_3233_BPL_190083
crossref_primary_10_1016_j_ijmedinf_2022_104845
crossref_primary_10_1038_jcbfm_2015_172
crossref_primary_10_1002_alz_13741
crossref_primary_10_1002_alz_12215
crossref_primary_10_1016_j_mad_2020_111332
crossref_primary_10_1016_j_arr_2015_07_007
crossref_primary_10_1038_nprot_2018_034
crossref_primary_10_1016_j_bbapap_2020_140428
crossref_primary_10_1126_scitranslmed_aaw8283
crossref_primary_10_3233_JAD_150675
crossref_primary_10_1186_s12877_021_02336_1
crossref_primary_10_1038_jcbfm_2015_147
crossref_primary_10_1371_journal_pbio_3000313
crossref_primary_10_1001_jamainternmed_2019_4911
crossref_primary_10_33590_emjneurol_10311025
crossref_primary_10_1186_s40478_019_0809_0
crossref_primary_10_3389_fnagi_2016_00276
crossref_primary_10_1136_bmjopen_2022_063485
crossref_primary_10_1002_mds_26721
crossref_primary_10_1093_brain_awaa406
crossref_primary_10_1161_STROKEAHA_119_024149
crossref_primary_10_3402_pba_v6_32397
crossref_primary_10_1016_j_ijmedinf_2021_104494
crossref_primary_10_1016_j_bbadis_2015_08_019
crossref_primary_10_1371_journal_pone_0263525
crossref_primary_10_1007_s11357_021_00422_1
crossref_primary_10_1016_j_jalz_2015_06_1885
crossref_primary_10_1038_jcbfm_2015_76
crossref_primary_10_31491_APT_2022_03_078
crossref_primary_10_1161_CIRCRESAHA_122_319951
crossref_primary_10_1097_CEH_0000000000000288
crossref_primary_10_1016_j_jalz_2015_12_007
crossref_primary_10_1186_s13024_021_00502_y
crossref_primary_10_1016_j_bbadis_2015_12_016
crossref_primary_10_1038_nrn_2017_48
crossref_primary_10_1161_STROKEAHA_118_021380
crossref_primary_10_1038_nrneurol_2017_188
crossref_primary_10_1038_nrneurol_2017_185
crossref_primary_10_1084_jem_20150656
crossref_primary_10_1016_j_cell_2015_10_067
crossref_primary_10_1002_alz_12157
crossref_primary_10_3389_fnagi_2021_788519
crossref_primary_10_3389_fphys_2021_645342
crossref_primary_10_1016_j_jalz_2018_07_222
crossref_primary_10_3233_JAD_180992
crossref_primary_10_1002_dad2_12332
crossref_primary_10_1089_neu_2022_0514
crossref_primary_10_1161_JAHA_116_004389
crossref_primary_10_1186_s12974_024_03162_z
crossref_primary_10_1176_appi_focus_15105
crossref_primary_10_1212_WNL_0000000000005259
crossref_primary_10_1038_s41597_023_02057_7
crossref_primary_10_1007_s10571_016_0334_7
crossref_primary_10_1016_j_bbadis_2016_02_010
crossref_primary_10_1016_j_jpba_2025_116818
crossref_primary_10_1016_j_nbd_2022_105986
crossref_primary_10_1016_j_jagp_2023_11_005
crossref_primary_10_3389_fncel_2016_00051
crossref_primary_10_1002_jnr_23592
crossref_primary_10_1016_j_celrep_2017_07_024
crossref_primary_10_1038_jcbfm_2015_164
crossref_primary_10_1161_STROKEAHA_117_017246
crossref_primary_10_1007_s00401_017_1717_7
crossref_primary_10_1007_s12035_015_9271_6
crossref_primary_10_1515_revneuro_2024_0040
crossref_primary_10_3233_JAD_220646
crossref_primary_10_1002_adma_202303180
crossref_primary_10_1111_jnc_13583
crossref_primary_10_1161_STROKEAHA_123_044172
crossref_primary_10_1212_WNL_0000000000004717
crossref_primary_10_1002_alz_12004
crossref_primary_10_1084_jem_20171406
crossref_primary_10_5937_mckg53_21900
crossref_primary_10_1212_WNL_0000000000004798
crossref_primary_10_3390_pharmaceutics13010122
crossref_primary_10_1016_j_pharmr_2025_100052
crossref_primary_10_1080_20010001_2018_1524815
crossref_primary_10_1080_20010001_2019_1616994
crossref_primary_10_1016_S0140_6736_15_00462_6
ContentType Journal Article
Copyright 2014 American Academy of Neurology.
Copyright_xml – notice: 2014 American Academy of Neurology.
CorporateAuthor ADRD 2013 Conference Organizing Committee
CorporateAuthor_xml – name: ADRD 2013 Conference Organizing Committee
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1212/WNL.0000000000000733
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1526-632X
ExternalDocumentID 25080517
Genre Review
Research Support, Non-U.S. Gov't
Journal Article
Practice Guideline
Research Support, N.I.H., Extramural
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: P50 AG005142
– fundername: NIA NIH HHS
  grantid: P50 AG023501
GroupedDBID ---
-~X
.XZ
.Z2
01R
0R~
123
1J1
29N
354
3PY
4Q1
4Q2
4Q3
53G
5RE
5VS
6PF
77Y
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AASXQ
AAWTL
AAXQO
AAYEP
ABBLC
ABIVO
ABJNI
ABOCM
ABPXF
ABVCZ
ABXYN
ABZZY
ACCJW
ACDDN
ACGFS
ACILI
ACLDA
ACOAL
ACWRI
ACXJB
ACZKN
ADGGA
AE6
AEBDS
AENEX
AFDTB
AFEXH
AFNMH
AFUWQ
AGINI
AHOMT
AHQNM
AHQVU
AHVBC
AIJEX
AJCLO
AKCTQ
AKULP
AKWKN
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMKUR
AMNEI
AOHHW
BOYCO
BQLVK
BYPQX
C45
CGR
CS3
CUY
CVF
DIWNM
DU5
E.X
EBS
ECM
EIF
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
GQDEL
HZ~
IKYAY
IN~
JF7
KD2
KMI
L-C
L7B
N9A
NPM
N~7
N~B
O9-
OAG
OAH
OBH
ODMTH
OHH
OHYEH
OL1
OLB
OLH
OLU
OLV
OLY
OLZ
OPX
OVD
OVDNE
OVIDH
OVLEI
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
RLZ
RXW
SJN
TEORI
V2I
VVN
W3M
WH7
WOQ
WOW
XSW
XXN
XYM
XYN
YBU
YFH
~9M
ID FETCH-LOGICAL-c5863-4df647fa371784619bc56fa254ab440107b8d4f6261ab5830bb0c97a73814e652
IngestDate Mon Jul 21 06:07:10 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License 2014 American Academy of Neurology.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c5863-4df647fa371784619bc56fa254ab440107b8d4f6261ab5830bb0c97a73814e652
OpenAccessLink https://n.neurology.org/content/neurology/83/9/851.full.pdf
PMID 25080517
ParticipantIDs pubmed_primary_25080517
PublicationCentury 2000
PublicationDate 2014-August-26
PublicationDateYYYYMMDD 2014-08-26
PublicationDate_xml – month: 08
  year: 2014
  text: 2014-August-26
  day: 26
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Neurology
PublicationTitleAlternate Neurology
PublicationYear 2014
References 22275317 - Mov Disord. 2012 Mar;27(3):349-56
22048062 - Nat Rev Neurosci. 2011 Dec;12(12):723-38
24283198 - N Engl J Med. 2013 Dec 12;369(24):2275-7
21514250 - Alzheimers Dement. 2011 May;7(3):263-9
22265587 - Alzheimers Dement. 2012 Jan;8(1):1-13
18981371 - Neurology. 2008 Nov 4;71(19):1496-9
12058088 - Neurology. 2002 Jun 11;58(11):1615-21
21514248 - Alzheimers Dement. 2011 May;7(3):280-92
24267647 - Neuron. 2013 Nov 20;80(4):844-66
14872045 - Neurology. 2004 Feb 10;62(3):506-8
21514249 - Alzheimers Dement. 2011 May;7(3):270-9
References_xml – reference: 18981371 - Neurology. 2008 Nov 4;71(19):1496-9
– reference: 14872045 - Neurology. 2004 Feb 10;62(3):506-8
– reference: 24283198 - N Engl J Med. 2013 Dec 12;369(24):2275-7
– reference: 21514248 - Alzheimers Dement. 2011 May;7(3):280-92
– reference: 12058088 - Neurology. 2002 Jun 11;58(11):1615-21
– reference: 22275317 - Mov Disord. 2012 Mar;27(3):349-56
– reference: 22048062 - Nat Rev Neurosci. 2011 Dec;12(12):723-38
– reference: 21514249 - Alzheimers Dement. 2011 May;7(3):270-9
– reference: 21514250 - Alzheimers Dement. 2011 May;7(3):263-9
– reference: 24267647 - Neuron. 2013 Nov 20;80(4):844-66
– reference: 22265587 - Alzheimers Dement. 2012 Jan;8(1):1-13
SSID ssj0015279
Score 2.447408
SecondaryResourceType review_article
Snippet The National Alzheimer's Project Act, signed into law in 2011, mandates a National Plan to Address Alzheimer's Disease that is updated annually. In the Plan,...
SourceID pubmed
SourceType Index Database
StartPage 851
SubjectTerms Alzheimer Disease
Dementia
Humans
United States
Title Recommendations of the Alzheimer's disease-related dementias conference
URI https://www.ncbi.nlm.nih.gov/pubmed/25080517
Volume 83
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8NAFB5cQLyI-y45CB4kmkxmSY51LW4nS73JTDKDBdsK6am_3jdL0lArLj2EkoEQ5r15-d72PYSODcVeImIc5jRjIRE4CUVCeYgLxWUaKaZyWyD7xNodcvdCXxoZU9NdMpJn-XhmX8l_pAr3QK6mS_YPkq0fCjfgP8gXriBhuP5KxsZ37PeVn4tUVvn-1vv4TfXsWBReVimY0HatALwsbECwJ0pTce67_ZoQ1dJ1NGPtcOxHPRf4dOVEk1TS_RA-sm_KzoQ97drM-2TxQsjK2l6Z9HSNmXt1W_-Vqa0pXZFfFXuIiQmmYs9c7e0lZiFL7ET02qC6yTRecbKGdUwdt-wXqw2fT9jq7tODY5OsftxRZDQE-dG3kgTYlhpusZ9Xp7i0q6V5NA9ehRmTamI7PudEMc98cyW80Pms1zHU0f4RU26IhSPPq2jF-xFByynFGppTg3W09OgrJTbQ7ZRuBEMdgG4EtW6clMGUZgS1ZgQTzdhEnZvr58t26IdmwGlLWRKSQjPCtUjATwdsGWcyp0wLTImQBJzpCI5gQTT4sbGQNE0iKaM844IDdCOKUbyFFgbDgdpBgaZRAQA1IrlMSRzrNOGSCQUAH1Cixuku2nZb8PrhmFFeq83Z-3ZlHy1PFOkALWo4iuoQcN1IHllxfAJhvUle
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recommendations+of+the+Alzheimer%27s+disease-related+dementias+conference&rft.jtitle=Neurology&rft.au=Montine%2C+Thomas+J&rft.au=Koroshetz%2C+Walter+J&rft.au=Babcock%2C+Debra&rft.au=Dickson%2C+Dennis+W&rft.date=2014-08-26&rft.eissn=1526-632X&rft.volume=83&rft.issue=9&rft.spage=851&rft_id=info:doi/10.1212%2FWNL.0000000000000733&rft_id=info%3Apmid%2F25080517&rft_id=info%3Apmid%2F25080517&rft.externalDocID=25080517